Biodexa Pharmaceuticals annual net debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Biodexa Pharmaceuticals Net Debt Growth & History (BDRX)
Biodexa Pharmaceuticals's net debt was −£8.5M for fiscal 2025.
View full Biodexa Pharmaceuticals company overviewBiodexa Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −£8.5M | −£7.4M | — |
| 2024 | 2024-12-31 | −£1.1M | £4.7M | — |
| 2023 | 2023-12-31 | −£5.8M | −£3.1M | — |
| 2022 | 2022-12-31 | −£2.7M | £7.2M | — |
| 2021 | 2021-12-31 | −£9.9M | −£2.6M | — |
| 2020 | 2020-12-31 | −£7.3M | £3.2M | — |
| 2019 | 2019-12-31 | −£10.5M | −£9.7M | — |
| 2018 | 2018-12-31 | −£841,000 | £5.8M | — |
| 2017 | 2017-12-31 | −£6.7M | £8.8M | — |
| 2016 | 2016-12-31 | −£15.4M | −£1.2M | — |
| 2015 | 2015-12-31 | −£14.2M | — | — |
Biodexa Pharmaceuticals quarterly net debt
Q4.18
Q4.19
Q4.20
Q4.21
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −£8.5M | −£7.4M | — |
| Q2 2025 | 2025-06-30 | −£3.5M | £1.3M | — |
| Q4 2024 | 2024-12-31 | −£1.1M | £4.7M | — |
| Q2 2024 | 2024-06-30 | −£4.9M | £182,000 | — |
| Q4 2023 | 2023-12-31 | −£5.8M | −£3.1M | — |
| Q2 2023 | 2023-06-30 | −£5.1M | — | — |
| Q4 2022 | 2022-12-31 | −£2.7M | £7.2M | — |
| Q4 2021 | 2021-12-31 | −£9.9M | −£2.6M | — |
| Q4 2020 | 2020-12-31 | −£7.3M | £3.2M | — |
| Q4 2019 | 2019-12-31 | −£10.5M | −£9.7M | — |
| Q4 2018 | 2018-12-31 | −£841,000 | — | — |
Biodexa Pharmaceuticals net debt trends
Over the last five fiscal years, Biodexa Pharmaceuticals's net debt decreased from −£7.3M to −£8.5M, a change of −£1.1M. The latest reported quarter, Q4 2025, shows −£8.5M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodexa Pharmaceuticals source filings ↗Community posts
Biodexa advances trial enrollment as research spending and cash use rise
Biodexa ($BDRX) reported that 92 of the planned 168 participants have entered its Serenta trial, while first-half research and development spending increased to £2.92 million from £1.67 million. Spending reflected the trial and manufacturin ...